Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HydroMARK Breast Biopsy Site Marker

K-Number: K210752 · 2021-04-14

ApplicantDevicor Medical Products, Inc.
Decision Date2021-04-14
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

HydroMARK Breast Biopsy Site Marker is a medical device manufactured by Devicor Medical Products, Inc.. It received FDA 510(k) clearance on 2021-04-14 under approval number K210752. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HydroMARK Breast Biopsy Site Marker?

HydroMARK Breast Biopsy Site Marker is a medical device that received FDA 510(k) clearance on 2021-04-14. It is manufactured by Devicor Medical Products, Inc.. The 510(k) number is K210752.

When was HydroMARK Breast Biopsy Site Marker approved by the FDA?

HydroMARK Breast Biopsy Site Marker received FDA 510(k) clearance on 2021-04-14, under approval number K210752.

What company makes HydroMARK Breast Biopsy Site Marker?

HydroMARK Breast Biopsy Site Marker is manufactured by Devicor Medical Products, Inc..

What is the FDA product code for HydroMARK Breast Biopsy Site Marker?

The FDA product code for HydroMARK Breast Biopsy Site Marker is NEU.

Related Clinical Trials

NCT06268405 Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings RECRUITING NCT06807502 Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device RECRUITING NCT04968990 Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation RECRUITING NCT05465161 STING MARK Universal Fiducial Marker System RECRUITING NCT06067503 Biomarkers to Detect Endocrine Therapy Resistance RECRUITING NCT07505797 ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) RECRUITING

Other Devices by Devicor Medical Products, Inc.

K153709Mammotome elite Biopsy System-13G Probe, Mammotome elite Biopsy System-10G Probe, Mammotome elite Biopsy System-Holster, Mammotome elite Biopsy System-13G Introducer Stylet, Mammotome elite Biopsy System-10G Introducer Stylet K161021HydroMARK Breast Biopsy Site Marker K152989Mammotome revolve Dual Vacuum Assist Biopsy System K170803HydroMARK Breast Biopsy Site Markers K203097HydroMARK Breast Biopsy Site Markers K202012Mammotome Revolve Dual Vacuum Assisted Biopsy (VAB) System

View all 14 devices →

Related Devices (Code: NEU)

K152510UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. K161021HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. K171767Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. K170803HydroMARK Breast Biopsy Site MarkersDevicor Medical Products, Inc. K170026Radiopaque Tissue MarkerViscus Biologics, LLC K170905Star Tissue MarkerScion Medical Technologies, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑